Kiniksa Pharmaceuticals Internationl PLC (KNSA:NASDAQ)
$41.91 -1.59 (-3.66%)
Analysed Kiniksa Pharmaceuticals Internationl PLC (KNSA:NASDAQ) News Sources
Kiniksa Pharmaceuticals International, plc (KNSA) Misses Q4 Earnings Estimates
Yahoo Finance UK
Kiniksa Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Portfolio Execution
Yahoo Finance
Kiniksa Pharmaceuticals International, plc Q4 2025 earnings preview
Seeking Alpha on MSN
Kiniksa Pharmaceuticals International Q4 Earnings Call Highlights
Yahoo Finance
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q4 2025 Earnings Call Transcript
Insider Monkey on MSN
Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
Markets Insider
Kiniksa outlines $900M–$920M 2026 ARCALYST revenue guidance as market penetration deepens
Seeking Alpha on MSN
Do Options Traders Know Something About KNSA Stock We Don't?
Zacks.com on MSN
1KNSA : Insights Ahead: Kiniksa Pharmaceuticals's Quarterly Earnings
Benzinga
Kiniksa (KNSA) Q4 2025 Earnings Call Transcript
The Globe and Mail
What is the current price of Kiniksa Pharmaceuticals Internationl PLC (KNSA:NASDAQ)?
The current price of Kiniksa Pharmaceuticals Internationl PLC (KNSA:NASDAQ) is $41.91.
Kiniksa Pharmaceuticals Internationl PLC (KNSA:NASDAQ) absolute price change since previous trading day?
The absolute price change of Kiniksa Pharmaceuticals Internationl PLC (KNSA:NASDAQ) since the previous trading day is $-1.59.
Kiniksa Pharmaceuticals Internationl PLC (KNSA:NASDAQ) percentage price change since previous trading day?
The percentage price change of Kiniksa Pharmaceuticals Internationl PLC (KNSA:NASDAQ) since the previous trading day is -3.66%.
What is This Week's average sentiment score for Kiniksa Pharmaceuticals Internationl PLC (KNSA:NASDAQ)?
This Week's average sentiment score for Kiniksa Pharmaceuticals Internationl PLC (KNSA:NASDAQ) is 87 out of 100.
What is This Week's average sentiment for Kiniksa Pharmaceuticals Internationl PLC (KNSA:NASDAQ)?
This Week's sentiment for Kiniksa Pharmaceuticals Internationl PLC (KNSA:NASDAQ) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.